OpGen recently launched the first Acuitas test, which is designed to detect the most common bacterial causes of complicated urinary tract infections.
The firm will begin initial trials for antibiotic-resistant urinary tract infection detection in UK hospitals in early 2018.
GenomeDx will have exclusive rights to distribute the molecular tests in most of the US, while Pathnostics continues to perform the assays in-house.
In PLOS this week: gene-environment interactions affecting BMI, transposon mutagenesis study of UTI-linked bacteria, and more.
Researchers have shown that metagenomic sequencing on the MinIon can identify the pathogen and antimicrobial resistance profile of UTIs in several hours.
Researchers are scouring samples for antibiotic resistance genes using sequencing, NBC News reports.
The test, called CloNeT, is based on a novel barcoding technology that links infecting bacteria to a database of antibiotic resistance profiles.
The goal is to develop a test that can identify the pathogen involved and predict antibiotic susceptibility within six hours of taking a urine sample.
The researchers are also developing the method in tandem with a more extensive pathogen profiling diagnostic platform from Swedish startup Q-linea.
The long-term goal of the project is to develop a single test for detecting an array of STDs and UTIs using Rheonix's fully automated point-of-care molecular diagnostic platform, called CARD.
CNN reports that researchers have tied a new variant to opioid addiction risk.
Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.
An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.
In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.